Dilon Technologies has filed a notice of an exempt offering of securities to raise $7,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Dilon Technologies is raising $7,500,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Michael Tiller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Dilon Technologies
Dilon Technologies will deliver clinically useful imaging and intraoperative systems appropriate for early disease diagnosis and surgical applications. The company operates a quality system that complies with all applicable regulations, standards and guidelines to deliver reliable technologies and products.DIAGNOSTIC IMAGING:Dilons cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer. The MBI procedure and its accessory for MBI guided breast biopsy has proven to detect cancers missed by Mammography and Ultrasound, while leading to fewer benign biopsies than MRI.Dilon is the exclusive North American distributor of GEs Discovery NM750b dual head MBI system. The Discovery NM 750b MBI system uses revolutionary and leading-edge, solid-state Cadmium Zinc Telluride (CZT) detectors to improve diagnostic accuracy in all types of patients.SURGICAL IMAGING:The Dilon Navigator Gamma Probe is one of the most widely used gamma probes for cancer surgery in the marketplace. The Dilon Navigator 2.0 combines the reliability and features of its predecessor, the Navigator GPS, with state-of-the-art wireless probe technology in a new, sleek design. Lightweight and compact, this system is the ultimate in portability. The Navigator system provides the best gamma probe value in the market.AIRWAY IMAGING:The CoPilot VL is an innovative and affordable video laryngoscope designed to make intubation and airway management quick and easy no matter where it is needed. Our patented Bougie Port system solves the issue of getting the endotracheal tube around the corner and into the trachea. The CoPilot VL was designed to be the new standard of care for airway management. Every patient. Every time.
To learn more about Dilon Technologies, visit http://www.dilon.com/
Contact:
Michael Tiller, Chief Financial Officer
757-269-4910
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.